Spondyloarthritis (SpA) and inflammatory bowel disease (IBD) are chronic autoinflammatory diseases that partially share the genetic predisposition and the unchecked inflammatory response linking the gut to the joints. The coexistence of both conditions in patients and the increased cross-risk ratios between SpA and IBD strongly suggest a shared pathophysiology. The prevalence of Enteropathic-related Spondyloarthritis (ESpA) in IBD patients shows a wide variation and may be underestimated. It is well accepted that the management of joint pain requires rheumatological expertise in conjunction with gastroenterologist assessment. In this view, we aimed at assessing, in a prospective study performed in a combined Gastro-Intestinal and Rheumatologic "GI-Rhe" clinic: (1) the prevalence of ESpA and other rheumatologic diseases in IBD patients with joint pain; (2) the features of the ESpA population; and (3) the diagnostic delay and the potential impact of the combined assessment. From November 2012 to December 2014, IBD patients with joint pain referring to a dedicated rheumatologist by the IBD-dedicated gastroenterologist were enrolled. Clinical and biochemical evaluations, joint involvement and disease activity assessment, diagnostic delay, and treatment were recorded. IBD patients (n = 269) with joint pain were jointly assessed in the "GI-Rhe" Unit. A diagnosis of ESpA was made in 50.5% of IBD patients with joint pain. ESpA patients showed a peripheral involvement in 53% of cases, axial in 20.6% and peripheral and axial in 26.4% of cases. ESpA patients had a higher prevalence of other autoimmune extra-intestinal manifestations and received more anti-TNF treatment compared with IBD patients. A mean diagnostic delay of 5.2. years was revealed in ESpA patients. Patients with joint disease onset in the 2002-2012 decade had reduced diagnostic delay compared with those with onset in the 1980-1990 and 1991-2001 decades. Diagnostic delay was further reduced for patients with joint onset in the last two years in conjunction with the establishment of the GI-Rhe clinic. Multidisciplinary approach improved management of rheumatic disorders in IBD patients allowing a more comprehensive care.

Conigliaro, P., Chimenti, M.s., Ascolani, M., Triggianese, P., Novelli, L., Onali, S., et al. (2016). Impact of a multidisciplinary approach in enteropathic spondyloarthritis patients. AUTOIMMUNITY REVIEWS, 15(2), 184-190 [10.1016/j.autrev.2015.11.002].

Impact of a multidisciplinary approach in enteropathic spondyloarthritis patients

CONIGLIARO, PAOLA;CHIMENTI, MARIA SOLE;Triggianese, P;ONALI, SARA;CALABRESE, EMMA;PALLONE, FRANCESCO;PERRICONE, ROBERTO;BIANCONE, LIVIA
2016-01-01

Abstract

Spondyloarthritis (SpA) and inflammatory bowel disease (IBD) are chronic autoinflammatory diseases that partially share the genetic predisposition and the unchecked inflammatory response linking the gut to the joints. The coexistence of both conditions in patients and the increased cross-risk ratios between SpA and IBD strongly suggest a shared pathophysiology. The prevalence of Enteropathic-related Spondyloarthritis (ESpA) in IBD patients shows a wide variation and may be underestimated. It is well accepted that the management of joint pain requires rheumatological expertise in conjunction with gastroenterologist assessment. In this view, we aimed at assessing, in a prospective study performed in a combined Gastro-Intestinal and Rheumatologic "GI-Rhe" clinic: (1) the prevalence of ESpA and other rheumatologic diseases in IBD patients with joint pain; (2) the features of the ESpA population; and (3) the diagnostic delay and the potential impact of the combined assessment. From November 2012 to December 2014, IBD patients with joint pain referring to a dedicated rheumatologist by the IBD-dedicated gastroenterologist were enrolled. Clinical and biochemical evaluations, joint involvement and disease activity assessment, diagnostic delay, and treatment were recorded. IBD patients (n = 269) with joint pain were jointly assessed in the "GI-Rhe" Unit. A diagnosis of ESpA was made in 50.5% of IBD patients with joint pain. ESpA patients showed a peripheral involvement in 53% of cases, axial in 20.6% and peripheral and axial in 26.4% of cases. ESpA patients had a higher prevalence of other autoimmune extra-intestinal manifestations and received more anti-TNF treatment compared with IBD patients. A mean diagnostic delay of 5.2. years was revealed in ESpA patients. Patients with joint disease onset in the 2002-2012 decade had reduced diagnostic delay compared with those with onset in the 1980-1990 and 1991-2001 decades. Diagnostic delay was further reduced for patients with joint onset in the last two years in conjunction with the establishment of the GI-Rhe clinic. Multidisciplinary approach improved management of rheumatic disorders in IBD patients allowing a more comprehensive care.
2016
Pubblicato
Rilevanza internazionale
Articolo
Esperti anonimi
Settore MED/06
English
Con Impact Factor ISI
Enteropathic spondyloarthritis; Inflammatory bowel disease; Management; Multidisciplinary approach; Genetic Predisposition to Disease; Humans; Inflammatory Bowel Diseases; Prevalence; Rheumatic Diseases; Spondylarthritis; Immunology; Immunology and Allergy; Medicine (all)
http://www.elsevier.com/locate/autrev
Conigliaro, P., Chimenti, M.s., Ascolani, M., Triggianese, P., Novelli, L., Onali, S., et al. (2016). Impact of a multidisciplinary approach in enteropathic spondyloarthritis patients. AUTOIMMUNITY REVIEWS, 15(2), 184-190 [10.1016/j.autrev.2015.11.002].
Conigliaro, P; Chimenti, Ms; Ascolani, M; Triggianese, P; Novelli, L; Onali, S; Lolli, E; Calabrese, E; Petruzziello, C; Pallone, F; Perricone, R; Biancone, L
Articolo su rivista
File in questo prodotto:
File Dimensione Formato  
Impact of a multidisciplinary approach in enteropathic.pdf

accesso aperto

Licenza: Copyright dell'editore
Dimensione 413.05 kB
Formato Adobe PDF
413.05 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/163879
Citazioni
  • ???jsp.display-item.citation.pmc??? 14
  • Scopus 40
  • ???jsp.display-item.citation.isi??? 44
social impact